Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Clinical Pharmaceutical Care in Nursing Home Residents as a Cornerstone for Drug-Related Problems Identification

M. Halačová, M. Mieresová, D. Černý, I. Plechatá, V. Špatenková, Z. Kalvach

. 2025 ; 18 (5) : e70222. [pub] -

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, pozorovací studie, multicentrická studie

Perzistentní odkaz   https://www.medvik.cz/link/bmc25015822

Grantová podpora
00023884 The Ministry of Health, Czech Republic-conceptual development of research organization (NHH)
IDCZ.02.01.01/00/22_008/0004607 The Project New Technologies for Translational Research in Pharmaceutical Sciences/NETPHARM
European Union

Rational prescribing in geriatrics represents an important ethical as well as socio-economic issue. The aim of this project was to analyze the drug-related problems (DRPs) among the Czech nursing home residents and increase public awareness of further possible employment of clinical pharmacists in social care. The project was designed as a multicenter observational study. A total of 16 nursing homes and 800 participants with an average age of 84.6 ± 7.3 years were included in the study. Of them, a DRP was noted in 93.3% of people. The total amount of DRPs identified was 2215, which means an average of 2.8 ± 1.6 DRPs per patient. The most common DRPs identified were 'overtreatment' (19.5%), 'undertreatment' (12.8%), inappropriate dose (10.6%), recommendations for laboratory monitoring (10.4%) and adverse effects (10.3%). Of different drug classes, BZDs (OR 16.6, 95% CI 1.0-270.2), PPIs (OR 2.5, 95% CI 1.1-5.6) and NSAIDs (OR 4.4, 95% CI 1.1-18.3) were identified to be most commonly associated with DRPs. The risk of DRP identification clearly increased with the number of drugs used, with seven drugs demonstrated as the best cut-off for predicting DRP identification (AUC 0.842, sensitivity 0.602; specificity 0.796). 'SENIOR' project has confirmed a high rate of excessive polypharmacy among nursing home residents in the Czech republic resulting in high risk of potential and manifested DRPs. The project emphasized the role of clinical pharmacists in optimizing safety and effectiveness of treatment among older nursing home residents.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25015822
003      
CZ-PrNML
005      
20250731091240.0
007      
ta
008      
250708s2025 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1111/cts.70222 $2 doi
035    __
$a (PubMed)40388195
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Halačová, Milada $u Department of Clinical Pharmacy, Na Homolce Hospital, Prague, Czech Republic $u Department of Pharmacology, Motol University Hospital and 2nd Faculty of Medicine, Charles University, Prague, Czech Republic $u Department of Anaesthesia and Intensive Care Medicine, Third Faculty of Medicine and FNKV University Hospital, Charles University, Prague, Czech Republic $1 https://orcid.org/0000000214480274
245    10
$a Clinical Pharmaceutical Care in Nursing Home Residents as a Cornerstone for Drug-Related Problems Identification / $c M. Halačová, M. Mieresová, D. Černý, I. Plechatá, V. Špatenková, Z. Kalvach
520    9_
$a Rational prescribing in geriatrics represents an important ethical as well as socio-economic issue. The aim of this project was to analyze the drug-related problems (DRPs) among the Czech nursing home residents and increase public awareness of further possible employment of clinical pharmacists in social care. The project was designed as a multicenter observational study. A total of 16 nursing homes and 800 participants with an average age of 84.6 ± 7.3 years were included in the study. Of them, a DRP was noted in 93.3% of people. The total amount of DRPs identified was 2215, which means an average of 2.8 ± 1.6 DRPs per patient. The most common DRPs identified were 'overtreatment' (19.5%), 'undertreatment' (12.8%), inappropriate dose (10.6%), recommendations for laboratory monitoring (10.4%) and adverse effects (10.3%). Of different drug classes, BZDs (OR 16.6, 95% CI 1.0-270.2), PPIs (OR 2.5, 95% CI 1.1-5.6) and NSAIDs (OR 4.4, 95% CI 1.1-18.3) were identified to be most commonly associated with DRPs. The risk of DRP identification clearly increased with the number of drugs used, with seven drugs demonstrated as the best cut-off for predicting DRP identification (AUC 0.842, sensitivity 0.602; specificity 0.796). 'SENIOR' project has confirmed a high rate of excessive polypharmacy among nursing home residents in the Czech republic resulting in high risk of potential and manifested DRPs. The project emphasized the role of clinical pharmacists in optimizing safety and effectiveness of treatment among older nursing home residents.
650    _2
$a lidé $7 D006801
650    12
$a pečovatelské domovy $x statistika a číselné údaje $7 D009735
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a senioři $7 D000368
650    12
$a nežádoucí účinky léčiv $x epidemiologie $x diagnóza $x prevence a kontrola $7 D064420
650    12
$a domovy pro seniory $x statistika a číselné údaje $7 D006707
650    12
$a farmaceutické služby $x organizace a řízení $7 D010593
650    12
$a nevhodné předepisování $x statistika a číselné údaje $x prevence a kontrola $7 D057970
650    _2
$a polypharmacy $7 D019338
650    _2
$a farmaceuti $7 D010595
651    _2
$a Česká republika $x epidemiologie $7 D018153
655    _2
$a časopisecké články $7 D016428
655    _2
$a pozorovací studie $7 D064888
655    _2
$a multicentrická studie $7 D016448
700    1_
$a Mieresová, Marie $u Department of Clinical Pharmacy, Na Homolce Hospital, Prague, Czech Republic $u Department of Pharmacology, Motol University Hospital and 2nd Faculty of Medicine, Charles University, Prague, Czech Republic $1 https://orcid.org/0000000203308479
700    1_
$a Černý, Dalibor $u Department of Clinical Pharmacy, Na Homolce Hospital, Prague, Czech Republic $u Institute of Pharmacology, General University Hospital and 1st Faculty of Medicine, Charles University, Prague, Czech Republic $1 https://orcid.org/0000000188925996 $7 jx20101201018
700    1_
$a Plechatá, Ivana $u Institute of the Drug Guide, Prague, Czech Republic
700    1_
$a Špatenková, Věra $u Neurointensive Care Unit, Liberec Regional Hospital, Liberec, Czech Republic $u Department of Anaesthesia and Intensive Care Medicine, Third Faculty of Medicine, Charles University, Prague, Czech Republic $1 https://orcid.org/0000000349890967 $7 xx0106171
700    1_
$a Kalvach, Zdeněk $u III. Internal Clinic-Endocrinology and Metabolism, General University Hospital and 1st Faculty of Medicine, Prague, Czech Republic
773    0_
$w MED00173319 $t Clinical and translational science $x 1752-8062 $g Roč. 18, č. 5 (2025), s. e70222
856    41
$u https://pubmed.ncbi.nlm.nih.gov/40388195 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250708 $b ABA008
991    __
$a 20250731091235 $b ABA008
999    __
$a ok $b bmc $g 2366567 $s 1252947
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2025 $b 18 $c 5 $d e70222 $e - $i 1752-8062 $m Clinical and translational science $n Clin Transl Sci $x MED00173319
GRA    __
$a 00023884 $p The Ministry of Health, Czech Republic-conceptual development of research organization (NHH)
GRA    __
$a IDCZ.02.01.01/00/22_008/0004607 $p The Project New Technologies for Translational Research in Pharmaceutical Sciences/NETPHARM
GRA    __
$p European Union
LZP    __
$a Pubmed-20250708

Najít záznam

Citační ukazatele

Možnosti archivace